Navigation Links
Encorium Group Provides Update to LOI with Respect to the Sale of its U.S. Business
Date:5/18/2009

uality, full-service support for their biopharmaceutical and medical device development programs. Encorium offers therapeutic expertise, experienced team management and advanced technologies. The Company has drug and biologics development as well as clinical trial experience across a wide variety of therapeutic areas such as infectious diseases, cardiovascular, vaccines, oncology, diabetes endocrinology/metabolism, gene therapy, immunology, neurology, gastroenterology, dermatology, hepatology, women's health and respiratory medicine. Encorium believes that its expertise in the design of complex clinical trials, its therapeutic experience and commitment to excellence, and its application of innovative technologies, offer its clients a means to more quickly and cost effectively move products through the clinical development process. Encorium is headquartered in Wayne, Pennsylvania with its European base of operations in Espoo, Finland. The Company has a geographic footprint that includes over one billion people in North America, Western/Central/Eastern Europe, Scandinavia, and the Baltics.

This press release contains forward-looking statements identified by words such as "estimate," "project," "expect," "intend," "believe," "anticipate" and similar expressions regarding the potential sale of the U.S. business and our expectations regarding the effects of such transactions. Those statements involve risks and uncertainties, and actual results could differ materially from those discussed. Factors that could cause or contribute to such differences include, but are not limited to: (i) the timing of the closing, if any, of the transaction; (ii) the completion to the purchaser's satisfaction of due diligence; (iii) our ability to negotiate a definitive agreements with the Purchaser; (iv) the possibility that the transaction may not close; and (vi) the risk that any distributions to stockholders in connection with the transaction and with respect to
'/>"/>

SOURCE Encorium Group, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Encorium Group Signs $6.2 Million of New Contracts Mainly for Vaccines Clinical Trials
2. Encorium Announces the Initiation of a Strategic Partnership With Prologue Research After the Postponement of Negotiations Regarding Its Planned Acquisition; Strategic Reorganization and Cost Reduction Plan Initiated as Strategic Alternatives are Investig
3. Baxter and The Alzheimers Disease Cooperative Study Group to Pursue a Phase III Study of Gammagard Liquid in Patients With Alzheimers Disease
4. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
5. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
6. President Clinton Highlights MWW Group at the 2007 Clinton Global Initiative for its Stop Neglected Tropical Disease Campaign
7. Ethics Group Asks USAID Inspector General to Investigate Legality of Grants to Soros Groups
8. Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline
9. Coley Pharmaceutical Group Diversifies Pipeline with First-in-Class TLR Antagonist for the Treatment of Systemic Lupus Erythematosus
10. Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development
11. Medivations MDV3100 Demonstrates Substantial PSA Reductions in First Patient Groups Treated in Phase 1-2 Hormone Refractory Prostate Cancer Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... 22, 2014  New data demonstrates that flibanserin, a ... form of female sexual dysfunction, Hypoactive Sexual Desire Disorder ... performance in premenopausal women when taken at bedtime. The ... North America,s (SMSNA) 20th Annual ... SMSNA accepted this study as a ...
(Date:11/22/2014)... , Nov. 21, 2014   Long Beach dentist , ... often called the gold standard in tooth replacement because they ... stable, long-lasting way to restore and preserve smiles and improve ... replace a missing tooth or as a part of a ... look and feel of a smile. The loss ...
(Date:11/22/2014)... 21, 2014  Particle Sciences, Inc (PSI), the ... and manufactured a new innovative vaginal ring for ... Development arm of Exeltis Pharmaceuticals.  According to ... at Particle Sciences, "This vaginal ring was developed ... sciences and modeling expertise.  We are thrilled it ...
Breaking Medicine Technology:Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 2Study on Efficacy and Sedation-Related Safety of Flibanserin in Premenopausal Women Released Today at Sexual Medicine Society of North America Meeting 3Long Beach Dentist, Dr. Rassouli, is Now Offering Dental Implants 2Particle Sciences' Clinical Trial Supplies Group Manufactures Innovative Vaginal Ring 2
(Date:11/22/2014)... A new AlignLife Chiropractic & Natural Health ... Greenville area. Dr. Chelsea Sineath, owner and chiropractor at ... her own clinic after working in another AlignLife office ... , AlignLife believes that the body can heal itself ... chiropractic care and rehabilitation to allow the spine to ...
(Date:11/22/2014)... November 23, 2014 PrettyTailor , ... with a new big promotion. Customers can buy new ... information, customers can visit its website. , As a ... and occasion dresses. It mainly provides four types of ... dresses and flower girl dresses. It also provides a ...
(Date:11/22/2014)... black prom dress will never go out of fashion. BellasDress.com, ... new items of black prom gowns . Now all ... up to 70% off. People throughout the world can enjoy ... made with the best materials, can make wearers feel comfortable. ... company provides these beautiful outfits in a huge range of ...
(Date:11/22/2014)... 2014 BambooFlooringChina.com is a famous ... proudly released its new collection of bamboo mats ; ... to 29% off. , According to the sales ... grass, making it a highly renewable resource. Their bamboo mats ... mixing color which comes from natural bamboo with caramel bamboo ...
(Date:11/22/2014)... New York, NY (PRWEB) November 22, 2014 ... Australia’s Therapeutics Goods Administration (TGA) approved it for ... Glutathione was approved and listed within the Therapeutic ... http://www.comlaw.gov.au/Details/F2014L01277 , Kyowa Hakko’s Setria® Glutathione ... Chem, a biotech specialist that sources and imports ...
Breaking Medicine News(10 mins):Health News:AlignLife of Downtown Greenville is Now Open and Accepting New Patients 2Health News:Customers Are Welcome to Shop at PrettyTailor.com 2Health News:New Black Prom Dresses from BellasDress.com 2Health News:Trendy Bamboo Mats Online Now By BambooFlooringChina.com 2Health News:Setria® Glutathione Now Available in Australia 2Health News:Setria® Glutathione Now Available in Australia 3
... rebuilding teams responding to the devastation across Greece caused ... space. A series of crisis map products based on ... aid damage assessment efforts following the activation of the ... than 60 people were killed and thousands left homeless ...
... 21 Baxa Corporation, a leading,provider of systems ... announces the addition of two new international product,distributors. ... Colombia and Pentafarma & Co. in The Dominican ... reach and expand product promotion in South,America and ...
... in Series A Funding from DCM and Split Rock ... today announced,the beta availability of its website. Caring.com will ... experts, helpful information,and resources, and a community of people ... the more than 34 million adults who are,caring for ...
... selected by high-level scientific peer review, will gather in Helsinki ... as 1.2 million from the fourth and final Call of ... allow the researchers to create teams in Europe to focus ... outstanding young scientists from around the world to create their ...
... plus insulin works best, researchers say , , FRIDAY, Sept. ... which insulin-plus-drug regimen might best control type 2 diabetes ... three strategies tested coming out on top. , "What ... the study can be recommended" as being superior to ...
... Brandeis neuroscientist Gina Turrigiano has been awarded a National ... grant totaling $2.5 million. She is one of 12 ... , According to NIH, the award is designed to ... approaches to major challenges in biomedical and behavioral research. ...
Cached Medicine News:Health News:Greeks get space-based help in wake of deadly fires 2Health News:Baxa Corporation Extends Global Reach With New Distribution Agreements in Colombia and the Dominican Republic 2Health News:New Resource for Taking Care of Aging Parents Available in Beta 2Health News:New Resource for Taking Care of Aging Parents Available in Beta 3Health News:2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki 2Health News:2007 EURYI: 20 researchers to receive Nobel Prize-sized awards in Helsinki 3Health News:No Clear Winner in Diabetes Treatment Trial 2Health News:No Clear Winner in Diabetes Treatment Trial 3